<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">abcimg</journal-id>
			<journal-title-group>
				<journal-title>ABC Imagem Cardiovascular</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Arq Bras Cardiol: Imagem cardiovasc.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="epub">2675-312X</issn>
			<publisher>
				<publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">abcimg.20240027i</article-id>
			<article-id pub-id-type="doi">10.36660/abcimg.20240027i</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Case Report</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>A Rare Case of Pulmonary Sarcoidosis With Extracranial Carotid System Involvement</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-4272-646X</contrib-id>
					<name>
						<surname>Barros</surname>
						<given-names>Fanilda Souto</given-names>
					</name>
					<role>Conception and design of the research and writing of the manuscript</role>
					<role>acquisition of data and analysis and interpretation of the data and critical revision of the manuscript for intellectual content</role>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0009-0000-4977-4056</contrib-id>
					<name>
						<surname>Silva</surname>
						<given-names>Halsted Alarcão Gomes Pereira da</given-names>
					</name>
					<role>acquisition of data and analysis and interpretation of the data</role>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Barros</surname>
						<given-names>Daniela Souto</given-names>
					</name>
					<role>acquisition of data and analysis and interpretation of the data</role>
					<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Santos</surname>
						<given-names>Simone Nascimento dos</given-names>
					</name>
					<role>critical revision of the manuscript for intellectual content</role>
					<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>
				<institution content-type="orgname">Instituto Fanilda Barros</institution>
				<addr-line>
					<named-content content-type="city">Vitória</named-content>
					<named-content content-type="state">ES</named-content>
				</addr-line>
				<country country="BR">Brazil</country>
				<institution content-type="original">Instituto Fanilda Barros, Vitória, ES – Brazil</institution>
			</aff>
			<aff id="aff2">
				<label>2</label>
				<institution content-type="orgname">Instituto Dante Pazzanese de Cardiologia</institution>
				<addr-line>
					<named-content content-type="city">São Paulo</named-content>
					<named-content content-type="state">SP</named-content>
				</addr-line>
				<country country="BR">Brazil</country>
				<institution content-type="original">Instituto Dante Pazzanese de Cardiologia, São Paulo, SP – Brazil</institution>
			</aff>
			<aff id="aff3">
				<label>3</label>
				<institution content-type="orgname">Hospital São Geraldo</institution>
				<addr-line>
					<named-content content-type="city">Juína</named-content>
					<named-content content-type="state">MT</named-content>
				</addr-line>
				<country country="BR">Brazil</country>
				<institution content-type="original">Hospital São Geraldo, Juína, MT – Brazil</institution>
			</aff>
			<aff id="aff4">
				<label>4</label>
				<institution content-type="orgname">Hospital Santa Cruz</institution>
				<addr-line>
					<named-content content-type="city">Curitiba</named-content>
					<named-content content-type="state">PR</named-content>
				</addr-line>
				<country country="BR">Brazil</country>
				<institution content-type="original">Hospital Santa Cruz, Curitiba, PR – Brazil</institution>
			</aff>
			<aff id="aff5">
				<label>5</label>
				<institution content-type="orgname">Eccos Diagnóstico Cardiovascular Avançado</institution>
				<addr-line>
					<named-content content-type="city">Brasília</named-content>
					<named-content content-type="state">DF</named-content>
				</addr-line>
				<country country="BR">Brazil</country>
				<institution content-type="original">Eccos Diagnóstico Cardiovascular Avançado, Brasília, DF – Brazil</institution>
			</aff>
			<author-notes>
				<corresp id="c01"><bold>Mailing Address: Simone Nascimento dos Santos</bold> • ECCOS Diagnóstico Cardiovascular. SMDB Conj 16 Lote 5 Casa A. Postal Code: 71680-160. Brasília, DF – Brazil E-mail: <email>simone.eccos@gmail.com</email>
				</corresp>
				<fn fn-type="conflict">
					<p>Potential Conflict of Interest</p>
					<p>No potential conflict of interest relevant to this article was reported.</p>
				</fn>
				<fn fn-type="edited-by">
					<p>Editor responsible for the review: Marcelo Tavares</p>
				</fn>
			</author-notes>
			<pub-date date-type="pub" publication-format="electronic">
				<day>16</day>
				<month>05</month>
				<year>2024</year>
			</pub-date>
			<pub-date date-type="collection" publication-format="electronic">
				<month>05</month>
				<year>2024</year>
			</pub-date>
			<volume>37</volume>
			<issue>2</issue>
			<elocation-id>e20240027</elocation-id>
			<history>
				<date date-type="received">
					<day>23</day>
					<month>03</month>
					<year>2024</year>
				</date>
				<date date-type="rev-recd">
					<day>25</day>
					<month>03</month>
					<year>2024</year>
				</date>
				<date date-type="accepted">
					<day>25</day>
					<month>03</month>
					<year>2024</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
					<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<kwd-group xml:lang="en">
				<kwd>Endosonography</kwd>
				<kwd>Carotid Arteries</kwd>
				<kwd>Sarcoidosis</kwd>
			</kwd-group>
			<counts>
				<fig-count count="8"/>
				<table-count count="0"/>
				<equation-count count="0"/>
				<ref-count count="10"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>Introduction</title>
			<p>Sarcoidosis is a disease of unknown etiology, whose pathogenesis appears to involve genetic, immunologic, infectious, and environmental factors. It was first described in 1889 by Ernest Besnier and is also called Besnier-Boeck-Schaumann disease.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref></sup></p>
			<p>In sarcoidosis, a noninfectious inflammatory process leads to the formation of granulomas, which predominantly affect the lungs and intrathoracic lymph nodes in approximately 90% to 95% of cases. Close to 30% of patients with sarcoidosis present with extrapulmonary involvement, which may be the primary manifestation of the disease or occur in isolation.<sup><xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref></sup></p>
			<p>Involvement of cervical vessels is an uncommon manifestation and seldom described in the literature. This is a case report and literature review aiming to understand and highlight the need to assess possible extrapulmonary sites using multimodal imaging, as well as the monitoring of these sites after initiation of drug treatment, with a focus on ultrasound findings.</p>
		</sec>
		<sec sec-type="cases">
			<title>Case report</title>
			<p>A 61-year-old woman with complaints of headache and bilateral neck pain for approximately 6 months in association with weight loss and asthenia attended an appointment with a rheumatologist, who requested laboratory tests and an ultrasound of the carotid and vertebral arteries as initial diagnostic tests. Vascular ultrasound (VUS) of the carotid and vertebral arteries showed marked diffuse bilateral perivascular thickening along the common carotid artery, without involvement of the internal and external branches. The vascular lumen of the cervical vessels was also preserved (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>).</p>
			<p>
				<fig id="f01">
					<label>Figure 1</label>
					<caption>
						<title>– B-mode ultrasound images of the left common carotid artery demonstrating the presence of significant circumferential perivascular thickening in the (A) transverse and (B) longitudinal views. Color flow mapping showing (C and D) preserved flow and perivascular thickening along the common carotid artery without involvement of the internal and external carotid arteries. LCCA: left common carotid artery.</title>
					</caption>
					<graphic xlink:href="2675-312X-abcimg-37-02-e20240027-gf01.tif"/>
				</fig>
			</p>
			<p>
				<fig id="f02">
					<label>Figure 2</label>
					<caption>
						<title>– Ultrasound of the right common carotid artery demonstrating A) preserved intima-media thickness in the longitudinal view, B) cervical lymphadenopathy in the transverse view, and C) perivascular thickening in the longitudinal view. RCCA: right common carotid artery.</title>
					</caption>
					<graphic xlink:href="2675-312X-abcimg-37-02-e20240027-gf02.tif"/>
				</fig>
			</p>
			<p>The patient’s past pathological history included previous surgery for meningioma 2 years ago. The histological report indicated the presence of noncaseating granulomatous inflammation, with sarcoidosis being the leading diagnostic hypothesis (<xref ref-type="fig" rid="f03">Figure 3</xref>). The patient then underwent computed tomography of the chest, with findings consistent with pulmonary sarcoidosis.</p>
			<p>
				<fig id="f03">
					<label>Figure 3</label>
					<caption>
						<title>– Immunohistochemistry of the meninges identified areas of fibrosis, formation of noncaseating epithelioid granulomas, and structures suggestive of asteroid and Schumann bodies, findings consistent with a predominantly histiocytic granulomatous inflammatory process.</title>
					</caption>
					<graphic xlink:href="2675-312X-abcimg-37-02-e20240027-gf03.tif"/>
				</fig>
			</p>
			<p>Treatment with oral prednisone was initiated. There was improvement of systemic symptoms and regression of edema and cervical pain after 2 months of treatment. VUS of the carotid and vertebral arteries was performed 6 months after the start of drug treatment and demonstrated partial regression of perivascular edema bilaterally, and ultrasound follow-up was scheduled every 6 months (<xref ref-type="fig" rid="f04">Figure 4</xref>).</p>
			<p>
				<fig id="f04">
					<label>Figure 4</label>
					<caption>
						<title>– Ultrasound of the common carotid arteries demonstrating a reduction in perivascular thickening bilaterally, after the start of clinical treatment.</title>
					</caption>
					<graphic xlink:href="2675-312X-abcimg-37-02-e20240027-gf04.tif"/>
				</fig>
			</p>
		</sec>
		<sec sec-type="discussion">
			<title>Discussion</title>
			<p>Sarcoidosis is a multisystem inflammatory disease with an heterogenous presentation and clinical course, which can affect any organ and progress from spontaneous remission to multiple organ dysfunction. This heterogeneity, associated with the overlap of symptoms with other more common diseases, often leads to diagnostic uncertainty and treatment delays. The diagnosis of sarcoidosis is based on three parameters: a) clinical and imaging presentations consistent with the disease; b) evidence of noncaseating granulomas; and c) exclusion of alternative diagnoses. However, diagnostic confirmation may be challenging in the absence of pronounced chest or skin manifestations.</p>
			<p>In case of neck pain, other diseases must be discarded, such as carotid or vertebral dissection, Takayasu’s arteritis, thyroiditis, or transient perivascular inflammation of the carotid artery (TIPIC syndrome).<sup><xref ref-type="bibr" rid="B6">6</xref></sup></p>
			<p>In this case report, B-mode ultrasound images in the transverse and longitudinal views showed extensive perivascular involvement, including the common carotid arteries but sparing the internal carotid arteries. Some features of sarcoidosis overlap with those of Takayasu’s arteritis, such as long-term fatigue , weight loss, neck pain, and preservation of the carotid branches. However, in the case presented in this report, the lesions were extravascular, the intima-media complex was preserved, and the vessel lumen was not reduced, unlike echocardiographic findings of Takayasu’s arteritis, in which there is a concentric thickening of the intima-media complex involving the posterior and anterior vessel walls, leading to a reduction in the vessel lumen.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
			<p>Perivascular inflammation of the carotid arteries is described in TIPIC syndrome, a rare condition characterized by neck pain and echocardiographic findings similar to those described in our patient. Its differentiation from sarcoidosis was made based on the location, the persistence of the inflammatory process, and the presence of cervical lymphadenopathy. The most frequent site of carotid artery involvement in patients with TIPIC is the carotid bifurcation, more precisely the bulbar region.<sup><xref ref-type="bibr" rid="B8">8</xref></sup></p>
			<p>Corticosteroid therapy remains the first-line treatment for sarcoidosis, except when contraindicated.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> If the disease is not controlled in the induction phase (generally within 3 to 6 months), the use of immunosuppressants as second-line treatment can be considered.<sup><xref ref-type="bibr" rid="B10">10</xref></sup></p>
		</sec>
		<sec sec-type="conclusions">
			<title>Conclusion</title>
			<p>Sarcoidosis is an inflammatory disease with a challenging diagnosis, in which vascular involvement is extremely rare. The VUS proved to be a reliable tool in the detection of perivascular inflammatory involvement of the extracranial carotid artery and cervical lymph nodes, which was crucial in the differential diagnosis between sarcoidosis and other nonatherosclerotic diseases involving the cervical vessels.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>References</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. Besnier EH. Lupus Pernio de La Face; Synovites Fongueuses (Scrofulo-Tuberculeuses) Symétriques Des Extrémités Supérieures. Ann Derm Syph. 1889;10:545-9.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Besnier</surname>
							<given-names>EH</given-names>
						</name>
					</person-group>
					<article-title>Lupus Pernio de La Face; Synovites Fongueuses (Scrofulo-Tuberculeuses) Symétriques Des Extrémités Supérieures</article-title>
					<source>Ann Derm Syph</source>
					<year>1889</year>
					<volume>10</volume>
					<fpage>545</fpage>
					<lpage>549</lpage>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Hem E. Boeck's sarcoidosis--a centennial. Int J Dermatol. 2000;39(7):545-9. doi: 10.1046/j.1365-4362.2000.00397.x.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hem</surname>
							<given-names>E</given-names>
						</name>
					</person-group>
					<article-title>Boeck's sarcoidosis--a centennial</article-title>
					<source>Int J Dermatol</source>
					<year>2000</year>
					<volume>39</volume>
					<issue>7</issue>
					<fpage>545</fpage>
					<lpage>549</lpage>
					<pub-id pub-id-type="doi">10.1046/j.1365-4362.2000.00397.x</pub-id>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Kouranos V, Wells AU. The Role of Primary Care in Sarcoidosis. Curr Opin Pulm Med. 2023;29(5):493-500. doi: 10.1097/MCP.0000000000000991.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kouranos</surname>
							<given-names>V</given-names>
						</name>
						<name>
							<surname>Wells</surname>
							<given-names>AU</given-names>
						</name>
					</person-group>
					<article-title>The Role of Primary Care in Sarcoidosis</article-title>
					<source>Curr Opin Pulm Med</source>
					<year>2023</year>
					<volume>29</volume>
					<issue>5</issue>
					<fpage>493</fpage>
					<lpage>500</lpage>
					<pub-id>10.1097/MCP.0000000000000991</pub-id>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Costabel U. Sarcoidosis: Clinical Update. Eur Respir J Suppl. 2001;32:56s-68s. doi: 10.1183/09031936.01.18s320056.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Costabel</surname>
							<given-names>U</given-names>
						</name>
					</person-group>
					<article-title>Sarcoidosis: Clinical Update</article-title>
					<source>Eur Respir J Suppl</source>
					<year>2001</year>
					<volume>32</volume>
					<fpage>56s</fpage>
					<lpage>68s</lpage>
					<pub-id>10.1183/09031936.01.18s320056</pub-id>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(8):e26-e51. doi: 10.1164/rccm.202002-0251ST.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Crouser</surname>
							<given-names>ED</given-names>
						</name>
						<name>
							<surname>Maier</surname>
							<given-names>LA</given-names>
						</name>
						<name>
							<surname>Wilson</surname>
							<given-names>KC</given-names>
						</name>
						<name>
							<surname>Bonham</surname>
							<given-names>CA</given-names>
						</name>
						<name>
							<surname>Morgenthau</surname>
							<given-names>AS</given-names>
						</name>
						<name>
							<surname>Patterson</surname>
							<given-names>KC</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline</article-title>
					<source>Am J Respir Crit Care Med</source>
					<year>2020</year>
					<volume>201</volume>
					<issue>8</issue>
					<fpage>e26</fpage>
					<lpage>e51</lpage>
					<pub-id pub-id-type="doi">10.1164/rccm.202002-0251ST</pub-id>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Albricker ACL, Freire CMV, Santos SND, Alcantara ML, Cantisano AL, Porto CLL, et al. Recommendation Update for Vascular Ultrasound Evaluation of Carotid and Vertebral Artery Disease: DIC, CBR and SABCV - 2023. Arq Bras Cardiol. 2023;120(10):e20230695. doi: 10.36660/abc.20230695.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Albricker</surname>
							<given-names>ACL</given-names>
						</name>
						<name>
							<surname>Freire</surname>
							<given-names>CMV</given-names>
						</name>
						<name>
							<surname>Santos</surname>
							<given-names>SND</given-names>
						</name>
						<name>
							<surname>Alcantara</surname>
							<given-names>ML</given-names>
						</name>
						<name>
							<surname>Cantisano</surname>
							<given-names>AL</given-names>
						</name>
						<name>
							<surname>Porto</surname>
							<given-names>CLL</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Recommendation Update for Vascular Ultrasound Evaluation of Carotid and Vertebral Artery Disease: DIC, CBR and SABCV - 2023</article-title>
					<source>Arq Bras Cardiol</source>
					<year>2023</year>
					<volume>120</volume>
					<issue>10</issue>
					<elocation-id>e20230695</elocation-id>
					<pub-id pub-id-type="doi">10.36660/abc.20230695</pub-id>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Brkic A, Terslev L, Møller Døhn U, Torp-Pedersen S, Schmidt WA, Diamantopoulos AP. Clinical Applicability of Ultrasound in Systemic Large Vessel Vasculitides. Arthritis Rheumatol. 2019;71(11):1780-7. doi: 10.1002/art.41039.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Brkic</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Terslev</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Møller Døhn</surname>
							<given-names>U</given-names>
						</name>
						<name>
							<surname>Torp-Pedersen</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Schmidt</surname>
							<given-names>WA</given-names>
						</name>
						<name>
							<surname>Diamantopoulos</surname>
							<given-names>AP</given-names>
						</name>
					</person-group>
					<article-title>Clinical Applicability of Ultrasound in Systemic Large Vessel Vasculitides</article-title>
					<source>Arthritis Rheumatol</source>
					<year>2019</year>
					<volume>71</volume>
					<issue>11</issue>
					<fpage>1780</fpage>
					<lpage>1787</lpage>
					<pub-id pub-id-type="doi">10.1002/art.41039</pub-id>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Barros FS, Santos SN, Barros DS, Cunha SS, Albricker AL, Petisco ACG. Transient Perivascular Inflammation of the Carotid Artery (TIPIC): Vascular Ultrasonography Role. Arq Bras Cardiol: Imagem Cardiovasc. 2023;36(2):e20230019. doi: 10.36660/abcimg.20230019i.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Barros</surname>
							<given-names>FS</given-names>
						</name>
						<name>
							<surname>Santos</surname>
							<given-names>SN</given-names>
						</name>
						<name>
							<surname>Barros</surname>
							<given-names>DS</given-names>
						</name>
						<name>
							<surname>Cunha</surname>
							<given-names>SS</given-names>
						</name>
						<name>
							<surname>Albricker</surname>
							<given-names>AL</given-names>
						</name>
						<name>
							<surname>Petisco</surname>
							<given-names>ACG</given-names>
						</name>
					</person-group>
					<article-title>Transient Perivascular Inflammation of the Carotid Artery (TIPIC): Vascular Ultrasonography Role</article-title>
					<source>Arq Bras Cardiol: Imagem Cardiovasc</source>
					<year>2023</year>
					<volume>36</volume>
					<issue>2</issue>
					<elocation-id>e20230019</elocation-id>
					<pub-id pub-id-type="doi">10.36660/abcimg.20230019i</pub-id>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A, et al. ERS Clinical Practice Guidelines on Treatment of Sarcoidosis. Eur Respir J. 2021;58(6):2004079. doi: 10.1183/13993003.04079-2020.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Baughman</surname>
							<given-names>RP</given-names>
						</name>
						<name>
							<surname>Valeyre</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Korsten</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Mathioudakis</surname>
							<given-names>AG</given-names>
						</name>
						<name>
							<surname>Wuyts</surname>
							<given-names>WA</given-names>
						</name>
						<name>
							<surname>Wells</surname>
							<given-names>A</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>ERS Clinical Practice Guidelines on Treatment of Sarcoidosis</article-title>
					<source>Eur Respir J</source>
					<year>2021</year>
					<volume>58</volume>
					<issue>6</issue>
					<size units="pages">2004079</size>
					<pub-id pub-id-type="doi">10.1183/13993003.04079-2020</pub-id>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Hamzeh N, Voelker A, Forssén A, Gottschall EB, Rose C, Mroz P, et al. Efficacy of Mycophenolate Mofetil in Sarcoidosis. Respir Med. 2014;108(11):1663-9. doi: 10.1016/j.rmed.2014.09.013.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hamzeh</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Voelker</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Forssén</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Gottschall</surname>
							<given-names>EB</given-names>
						</name>
						<name>
							<surname>Rose</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Mroz</surname>
							<given-names>P</given-names>
						</name>
						<etal>et al</etal>
					</person-group>
					<article-title>Efficacy of Mycophenolate Mofetil in Sarcoidosis</article-title>
					<source>Respir Med</source>
					<year>2014</year>
					<volume>108</volume>
					<issue>11</issue>
					<fpage>1663</fpage>
					<lpage>1669</lpage>
					<pub-id>10.1016/j.rmed.2014.09.013</pub-id>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="other">
				<label/>
				<p>Study Association</p>
				<p>This study is not associated with any thesis or dissertation work.</p>
			</fn>
			<fn fn-type="other">
				<label/>
				<p>Ethics Approval and Consent to Participate</p>
				<p>This article does not contain any studies with human participants or animals performed by any of the authors.</p>
			</fn>
		</fn-group>
		<fn-group>
			<fn fn-type="financial-disclosure">
				<p>Sources of Funding</p>
				<p>There were no external funding sources for this study.</p>
			</fn>
		</fn-group>
	</back>
	<sub-article article-type="translation" id="TRpt" xml:lang="pt">
		<front-stub>
			<article-id pub-id-type="doi">10.36660/abcimg.20240027</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Relato de Caso</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Achado Raro de Sarcoidose Pulmonar com Acometimento do Sistema Carotídeo Extracraniano</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-4272-646X</contrib-id>
					<name>
						<surname>Barros</surname>
						<given-names>Fanilda Souto</given-names>
					</name>
					<role>Concepção e desenho da pesquisa e redação do manuscrito</role>
					<role>obtenção de dados e análise e interpretação dos dados</role>
					<role>revisão crítica do manuscrito quanto ao conteúdo intelectual importante</role>
					<xref ref-type="aff" rid="aff1002"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0009-0000-4977-4056</contrib-id>
					<name>
						<surname>Silva</surname>
						<given-names>Halsted Alarcão Gomes Pereira da</given-names>
					</name>
					<role>obtenção de dados e análise e interpretação dos dados</role>
					<xref ref-type="aff" rid="aff2002"><sup>2</sup></xref>
					<xref ref-type="aff" rid="aff3002"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Barros</surname>
						<given-names>Daniela Souto</given-names>
					</name>
					<role>obtenção de dados e análise e interpretação dos dados</role>
					<xref ref-type="aff" rid="aff4002"><sup>4</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Santos</surname>
						<given-names>Simone Nascimento dos</given-names>
					</name>
					<role>revisão crítica do manuscrito quanto ao conteúdo intelectual importante</role>
					<xref ref-type="aff" rid="aff5002"><sup>5</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1002">
				<label>1</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Instituto Fanilda Barros, Vitória, ES – Brasil</institution>
			</aff>
			<aff id="aff2002">
				<label>2</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Instituto Dante Pazzanese de Cardiologia, São Paulo, SP – Brasil</institution>
			</aff>
			<aff id="aff3002">
				<label>3</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Hospital São Geraldo, Juína, MT – Brasil</institution>
			</aff>
			<aff id="aff4002">
				<label>4</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Hospital Santa Cruz, Curitiba, PR – Brasil</institution>
			</aff>
			<aff id="aff5002">
				<label>5</label>
				<country country="BR">Brasil</country>
				<institution content-type="original">Eccos Diagnóstico Cardiovascular Avançado, Brasília, DF – Brasil</institution>
			</aff>
			<author-notes>
				<corresp id="c01002"><bold>Correspondência: Simone Nascimento dos Santos</bold> • ECCOS Diagnóstico Cardiovascular. SMDB Conj 16 Lote 5 Casa A. CEP: 71680-160. Brasília, DF – Brasil E-mail: simone.eccos@gmail.com </corresp>
				<fn fn-type="conflict">
					<p>Potencial Conflito de Interesse</p>
					<p>Declaro não haver conflito de interesses pertinentes.</p>
				</fn>
				<fn fn-type="edited-by">
					<p>Editor responsável pela revisão: Marcelo Tavares</p>
				</fn>
			</author-notes>
			<kwd-group xml:lang="pt">
				<kwd>Ultrassonografia</kwd>
				<kwd>Artérias carótidas</kwd>
				<kwd>Sarcoidose</kwd>
			</kwd-group>
		</front-stub>
		<body>
			<sec sec-type="intro">
				<title>Introdução</title>
				<p>A sarcoidose é considerada uma doença de etiologia desconhecida, cuja patogênese parece envolver fatores genéticos, imunológicos, infecciosos e ambientais. Essa doença foi descrita pela primeira vez em 1889 por Ernest Besnier, sendo também denominada doença de Besnier-Boeck-Schaumann.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref></sup></p>
				<p>Na sarcoidose, ocorre um processo inflamatório não infeccioso que evolui para a formação de granulomas, acometendo predominantemente os pulmões e linfonodos intratorácicos em cerca de 90 a 95% dos casos. Cerca de 30% dos pacientes com sarcoidose apresentam envolvimento extrapulmonar, podendo ser a manifestação primária da doença ou, até mesmo, o único órgão acometido de forma isolada.<sup><xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref></sup></p>
				<p>O acometimento de vasos cervicais é uma manifestação incomum e pouco descrita na literatura. Apresentamos um relato de caso e revisão da literatura, com foco na compreensão e necessidade de avaliação de possíveis sítios extrapulmonares por meio de imagem multimodal, assim como do acompanhamento desses sítios após o início do tratamento medicamentoso, dando ênfase para as alterações ultrassonográficas.</p>
			</sec>
			<sec sec-type="cases">
				<title>Relato de caso</title>
				<p>Paciente de 61 anos, do sexo feminino, com quadro de cefaleia e dor cervical bilateral há cerca de 6 meses associado a perda de peso e astenia. Realizou consulta clínica com médico reumatologista, que, entre os exames de investigação diagnóstica iniciais, solicitou avaliação laboratorial e ultrassonografia das artérias carótidas e vertebrais. A ultrassonografia vascular (USV) das artérias carótidas e vertebrais evidenciou um acentuado espessamento difuso perivascular ao longo da carótida comum, preservando os ramos interno e externo, bilateralmente. O lúmen vascular dos vasos cervicais se apresentava preservado (<xref ref-type="fig" rid="f01002">Figuras 1</xref> e <xref ref-type="fig" rid="f02002">2</xref>).</p>
				<p>
					<fig id="f01002">
						<label>Figura 1</label>
						<caption>
							<title>– Ultrassonografia no modo B da artéria carótida comum esquerda demonstrando presença de espessamento perivascular circunferencial importante no (A) corte transversal e no (B) corte longitudinal. Nas imagens C e D, pode-se observar o fluxo preservado ao mapeamento de fluxo em cores e espessamento perivascular ao longo da carótida comum sem envolvimento das carótidas interna e externa. ACCE: artéria carótida comum esquerda.</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-02-e20240027-gf01-pt.tif"/>
					</fig>
				</p>
				<p>
					<fig id="f02002">
						<label>Figura 2</label>
						<caption>
							<title>– Ultrassonografia da artéria carótida comum direita demonstrando (A) espessura médio-intimal preservada no corte longitudinal. Nas imagens B e C (corte transversal e longitudinal), evidencia-se a presença de linfonodomegalia cervical e espessamento perivascular, respectivamente. ACCD: artéria carótida comum direita.</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-02-e20240027-gf02-pt.tif"/>
					</fig>
				</p>
				<p>Na história patológica pregressa dessa paciente, ela relatou cirurgia prévia de meningioma há 2 anos, com o laudo histológico evidenciando a presença de processo inflamatório granulomatoso não caseoso, tendo como principal hipótese o diagnóstico de sarcoidose (<xref ref-type="fig" rid="f03002">Figura 3</xref>).</p>
				<p>
					<fig id="f03002">
						<label>Figura 3</label>
						<caption>
							<title>– Estudo imuno-histoquímico de amostra de meninge exibindo áreas de fibrose, formação de granulomas epitelioides “secos”, com estruturas sugestivas de corpos asteroides e corpúsculos de Schumann, achados consistentes com um processo inflamatório predominantemente histiocítico granulomatoso.</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-02-e20240027-gf03-pt.tif"/>
					</fig>
				</p>
				<p>Dando continuidade à investigação diagnóstica, a paciente foi submetida a tomografia computadorizada de tórax, que demonstrou achados compatíveis com sarcoidose pulmonar.</p>
				<p>Foi, então, iniciado o tratamento clínico com prednisona oral. A paciente apresentou melhora dos sintomas sistêmicos e regressão do edema e da dor cervical cerca de 2 meses após o início do tratamento. A USV das artérias carótidas e vertebrais, realizada 6 meses após o início do tratamento medicamentoso, demonstrou regressão parcial do edema perivascular bilateralmente, tendo sido programado o acompanhamento ultrassonográfico a cada 6 meses (<xref ref-type="fig" rid="f04002">Figura 4</xref>).</p>
				<p>
					<fig id="f04002">
						<label>Figura 4</label>
						<caption>
							<title>– Ultrassonografia das artérias carótidas comuns demonstrando redução do espessamento perivascular bilateralmente, após o início do tratamento clínico.</title>
						</caption>
						<graphic xlink:href="2675-312X-abcimg-37-02-e20240027-gf04-pt.tif"/>
					</fig>
				</p>
			</sec>
			<sec sec-type="discussion">
				<title>Discussão</title>
				<p>A sarcoidose é uma doença inflamatória multissistêmica, com apresentação e curso clínico variáveis, podendo afetar qualquer órgão e evoluir desde remissão espontânea até disfunção de múltiplos órgãos. Essa diversidade clínica, associada à semelhança com outras doenças mais comuns, muitas vezes causa incerteza diagnóstica e atrasos no tratamento. O diagnóstico da sarcoidose é fundamentado em três parâmetros: a) apresentação clínica-imagiológica compatível com a doença; b) evidência de granulomas não caseosos; e c) exclusão de diagnósticos alternativos. Entretanto, a sua confirmação pode ser dificultada pela ausência de manifestações torácicas ou cutâneas evidentes.</p>
				<p>Diante da dor cervical, faz-se necessário afastar outras doenças, como a dissecção carotídea ou vertebral, a arterite de Takayasu, tireoidites ou processo perivascular inflamatório transitório (síndrome TIPIC).<sup><xref ref-type="bibr" rid="B6">6</xref></sup></p>
				<p>Neste relato de caso, as imagens pelo modo B, em cortes transversais e longitudinais, mostraram um acometimento perivascular de grande extensão, envolvendo as artérias carótidas comuns e preservando as artérias carótidas internas. São observadas algumas semelhanças com a arterite de Takayasu no que tange ao quadro clínico arrastado de astenia, perda de peso e dor cervical, além da preservação dos ramos carotídeos. No entanto, no caso apresentado neste relato, pode-se observar que a lesão é extravascular, o complexo médio-intimal está preservado e não há redução do lúmen vascular, diferente dos achados ecográficos encontrados na arterite de Takayasu, na qual o complexo médio-intimal é espessado de modo concêntrico envolvendo a parede anterior e posterior do vaso, consequentemente reduzindo o lúmen vascular.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
				<p>O processo inflamatório perivascular das carótidas é descrito na síndrome TIPIC, que se trata de uma condição rara caracterizada por dor cervical e achados de imagens ecográficas semelhantes ao descrito na paciente deste relato de caso. A diferença se fez pelo local de acometimento, persistência do processo inflamatório e pela presença de adenomegalias na região cervical. O local mais frequente do envolvimento das artérias carótidas nos portadores de TIPIC é a bifurcação carotídea, mais precisamente a região bulbar.<sup><xref ref-type="bibr" rid="B8">8</xref></sup></p>
				<p>A corticoterapia continua sendo o tratamento de primeira linha para os casos de sarcoidose, salvo se houver contraindicações.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> Se não ocorrer o controle da doença na fase de indução (geralmente em 3 a 6 meses), pode-se considerar a introdução de imunossupressor como tratamento de segunda linha.<sup><xref ref-type="bibr" rid="B10">10</xref></sup></p>
			</sec>
			<sec sec-type="conclusions">
				<title>Conclusão</title>
				<p>A sarcoidose é considerada uma doença inflamatória de difícil diagnóstico, e o envolvimento vascular é extremamente raro. A ultrassonografia vascular se mostrou um método confiável para diagnosticar o envolvimento inflamatório perivascular da carótida extracraniana e dos gânglios da região cervical, fato que foi crucial para diferenciar o diagnóstico de sarcoidose de outras doenças não ateroscleróticas que envolvem os vasos cervicais.</p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="other">
					<p>Vinculação Acadêmica</p>
					<p>Não há vinculação deste estudo a programas de pós-graduação.</p>
				</fn>
				<fn fn-type="other">
					<p>Aprovação Ética e Consentimento Informado</p>
					<p>Este artigo não contém estudos com humanos ou animais realizados por nenhum dos autores.</p>
				</fn>
			</fn-group>
			<fn-group>
				<fn fn-type="financial-disclosure">
					<p>Fontes de Financiamento</p>
					<p>O presente estudo não teve fontes de financiamento externas.</p>
				</fn>
			</fn-group>
		</back>
	</sub-article>
</article>